SciFluor Life Sciences to Initiate Clinical Trials for 2 Retinal Diseases
SciFluor Life Sciences announced that an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now in effect for SF0166 Topical Ophthalmic Solution, enabling the company to ... Read more